Cited 28 times in
The Breast Cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박병우 | - |
dc.date.accessioned | 2015-04-23T17:06:38Z | - |
dc.date.available | 2015-04-23T17:06:38Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0368-2811 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/101839 | - |
dc.description.abstract | EPIDEMIOLOGY OF BREAST CANCER: The incidence and mortality of breast cancer are lower in Asia than in the West, particularly in post-menopausal women, but they are increasing. The age patterns of the incidence of breast cancer in Asia differ from in the West: in most Asian countries the peak incidence of breast cancer is at about age 45-50, whereas in western countries the incidence continues to increase even at older ages. Mortality is decreasing in western countries, whereas it is still increasing in Asian nations. There are many epidemiological factors involved in breast cancer, and important known risk factors include diet, obesity and diabetes. Asian studies found that high intake of isoflavones reduced the risk of breast cancer. PATHOLOGY OF BREAST CANCER: With regard to the pathology of breast cancer, for the molecular subtype, luminal A and luminal B are being used, while HER2 expression and rapid proliferation are also employed. Study results showed a somewhat higher prevalence of luminal A in Japanese compared with Americans. Ductal carcinoma in situ breast cancer is less frequent in Asian breast cancer patients than in Americans. The Working Group resolved to establish an international committee for pathological assessment of breast cancer in Asia. TREATMENT OF BREAST CANCER: Pharmacokinetics-pharmacodynamics studies are needed between ethnic backgrounds, investigating aromatase inhibitors and tamoxifen (endoxifen), as well as the effects of demographic factors such as diet, medical care, body mass index, etc. Correlations between adverse events and the clinical outcome also need to be studied. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | i13~i18 | - |
dc.relation.isPartOf | JAPANESE JOURNAL OF CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Asia/epidemiology | - |
dc.subject.MESH | Breast Neoplasms*/drug therapy | - |
dc.subject.MESH | Breast Neoplasms*/epidemiology | - |
dc.subject.MESH | Breast Neoplasms*/pathology | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Risk Factors | - |
dc.title | The Breast Cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학) | - |
dc.contributor.googleauthor | Masakazu Toi | - |
dc.contributor.googleauthor | Yasuo Ohashi | - |
dc.contributor.googleauthor | Adeline Seow | - |
dc.contributor.googleauthor | Takuya Moriya | - |
dc.contributor.googleauthor | Gary Tse | - |
dc.contributor.googleauthor | Hironobu Sasano | - |
dc.contributor.googleauthor | Byeong Woo Park | - |
dc.contributor.googleauthor | Louis W.C. Chow | - |
dc.contributor.googleauthor | Adriano V. Laudico | - |
dc.contributor.googleauthor | Cheng Har Yip | - |
dc.contributor.googleauthor | Ei Ueno | - |
dc.contributor.googleauthor | Hiroshi Ishiguro | - |
dc.contributor.googleauthor | Hiroko Bando | - |
dc.identifier.doi | 10.1093/jjco/hyq122 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01475 | - |
dc.relation.journalcode | J01207 | - |
dc.identifier.eissn | 1465-3621 | - |
dc.identifier.pmid | 20870914 | - |
dc.subject.keyword | breast cancer | - |
dc.subject.keyword | epidemiology | - |
dc.subject.keyword | hormone receptor | - |
dc.subject.keyword | aromatase | - |
dc.subject.keyword | HER2 | - |
dc.contributor.alternativeName | Park, Byeong Woo | - |
dc.contributor.affiliatedAuthor | Park, Byeong Woo | - |
dc.citation.volume | 40 | - |
dc.citation.startPage | 13 | - |
dc.citation.endPage | 18 | - |
dc.identifier.bibliographicCitation | JAPANESE JOURNAL OF CLINICAL ONCOLOGY, Vol.40 : 13-18, 2010 | - |
dc.identifier.rimsid | 54644 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.